Robert Rifkin, MD Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers Discusses Does Anti-BCMA CAR-T Cell Therapy Look Promising. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
